Specialist Updates 
Oncology

Three new cancer drugs listed on the PBS

Therapies are now subsidised for refractory glioblastoma, acute lymphoblastic leukaemia and neuroendocrine tumours
0
2 August 2019
Save
Please login to bookmark Close

Three new treatments have been listed on the PBS for people with aggressive forms of cancer, including refractory glioblastoma.

Subsidies for bevacizumab (Avastin), dasatinib (Sprycel) and lanreotide (Somatuline Autogel) were announced by federal Minister for Health Greg Hunt last week and came into effect on 1 August.

The drug indications are:

The listing for dasatinib in particular marks a world-first, with Australia the first country to list the drug for this form of leukaemia. It is designed to kill cancerous cells in the bone marrow to allow normal blood cell and platelet production to resume.

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Content that breaches the privacy of other individuals
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .